Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EARLY-COGN^3 - Smart Digital Solutions for EARLY Treatment of COGnitive Disability: a Neuropsychological, Neurophysiological and Neurobiological Perspective in Chronic Neurological Diseases - PNRR-MCNT2-2023-12377069

NCT06657274 is registered in ClinicalTrials.gov with IRCCS Centro San Giovanni di Dio Fatebenefratelli as lead sponsor.

NCT NCT06657274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06657274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EARLY-COGN^3 - Smart Digital Solutions for EARLY Treatment of COGnitive Disability: a Neuropsychological, Neurophysiological and Neurobiological Perspective in Chronic Neurological Diseases - PNRR-MCNT2-2023-12377069
Lead sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Phase
Not applicable
Overall status
Recruiting
Start date
December 9, 2024
Completion date
August 30, 2026
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment (mci), parkinson disease, subjective cognitive complaints (sccs)